ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Do we need new scales for assessing the risk of thromboembolic events and bleeding for patients with chronic kidney disease?

Journal: Ukrainian Journal of Nephrology and Dialysis (Vol.4, No. 68)

Publication Date:

Authors : ; ;

Page : 67-73

Keywords : Chronic kidney disease; risk scale; thromboembolic events; bleeding;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Chronic kidney disease (CKD) is a global health problem. Patients with CKD have an increased risk of thromboembolic complications and bleeding. It remains difficult to determine the benefits and risks of antiplatelet and anticoagulant therapy in patients with CKD, so an individualized risk assessment of each patient should be mandatory. To date, there are no specialized scales for assessing the risk of thromboembolic events and bleeding, which are focused on patients with CKD and take into account all the features of the course of CKD and the specific factors of their occurrence. In this work, we decided to conduct a detailed assessment of the accuracy of the currently accepted risk scales for thromboembolic events and bleeding in patients with CKD.

Last modified: 2021-01-26 00:09:32